Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
Soham Rej,1 Mahwesh Saleem,2,3 Nathan Herrmann,1,3 Anthi Stefatos,4 Allison Rau,3 Krista L Lanctôt1–3 1Department of Psychiatry, 2Department of Pharmacology and Toxicology, University of Toronto, 3Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, Toronto...
Guardado en:
Autores principales: | Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5349aca722cc4f3fa80bee510147b5a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men
por: Hiroshi Yoshida, et al.
Publicado: (2021) -
Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol
por: Jing Gao, et al.
Publicado: (2021) -
The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
por: Xu W, et al.
Publicado: (2020) -
Inhibición de la proteína de transferencia de ésteres de colesterol para el manejo de la enfermedad cardiovascular ateroesclerótica: el segundo acto "Una esperanza que renace"
por: Arteaga,Antonio, et al.
Publicado: (2011) -
Cerebrovascular Disease and Statins
por: Luis M. Beltrán Romero, et al.
Publicado: (2021)